Theraclion SA (EPA:ALTHE)
0.6710
-0.0110 (-1.61%)
Jul 13, 2026, 5:35 PM CET
Theraclion Market Cap
Theraclion has a market cap or net worth of €49.06 million as of July 13, 2026. Its market cap has increased by 225.26% in one year.
Market Cap
49.06M
Enterprise Value
56.91M
Revenue
652.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.67
Market Cap Chart
Since April 25, 2014, Theraclion's market cap has increased from 37.53M to 49.06M, an increase of 30.70%. That is a compound annual growth rate of 2.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 49.06M | 73.43% |
| Dec 31, 2025 | 28.28M | 85.64% |
| Dec 31, 2024 | 15.24M | -11.33% |
| Dec 29, 2023 | 17.18M | -34.28% |
| Dec 30, 2022 | 26.15M | -12.29% |
| Dec 31, 2021 | 29.81M | -3.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Carvolix | 408.78M |
| Eurobio Scientific Société anonyme | 207.41M |
| Median Technologies | 176.51M |
| Guerbet | 110.13M |
| Mauna Kea Technologies | 32.01M |
| Diagnostic Medical Systems | 30.97M |
| Novacyt | 29.31M |
| Implanet | 24.74M |